Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.

MLA

Katsumata, N., et al. “Phase II Study of S-1, an Oral Fluoropyrimidine, in Patients with Advanced or Recurrent Cervical Cancer.” Annals of Oncology, vol. 22, no. 6, June 2011, pp. 1353–57. EBSCOhost, https://doi.org/10.1093/annonc/mdq602.

APA

Katsumata, N., Hirai, Y., Kamiura, S., Sugiyama, T., Kokawa, K., Hatae, M., Nishimura, R., & Ochiai, K. (2011). Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer. Annals of Oncology, 22(6), 1353–1357. https://doi.org/10.1093/annonc/mdq602

Chicago

Katsumata, N., Y. Hirai, S. Kamiura, T. Sugiyama, K. Kokawa, M. Hatae, R. Nishimura, and K. Ochiai. 2011. “Phase II Study of S-1, an Oral Fluoropyrimidine, in Patients with Advanced or Recurrent Cervical Cancer.” Annals of Oncology 22 (6): 1353–57. doi:10.1093/annonc/mdq602.